IntrinsicIntrinsic
← All summaries

Churchill Capital Corp IX/Cayman

CCIXW
Financials & Chart →

Business Summary

Churchill Capital Corp IX (the "Company") is a blank check company, also known as a Special Purpose Acquisition Company (SPAC), incorporated on December 18, 2023, in the Cayman Islands, with the sole purpose of effecting a Business Combination with one or more businesses or entities . The Company has not generated any operating revenues to date and does not expect to do so until it consummates its initial Business Combination . Its efforts have been limited to organizational activities, activities related to its Initial Public Offering (IPO), and searching for and consummating a Business Combination, including the PlusAI Business Combination . The Company's business model is centered on identifying and acquiring a target business, thereby providing an alternative to a traditional IPO for the target company .

The Company's core business model involves leveraging the experience of its Management Team, M. Klein and Company (an affiliate of its Sponsor), and Strategic and Operating Partners to identify, evaluate, and execute attractive Business Combination opportunities . The Company aims to generate attractive returns for shareholders and enhance value by selecting a high-quality target at an attractive valuation, negotiating favorable acquisition terms, and improving the operational performance of the acquired company . Key target characteristics include compelling long-term growth prospects, opportunities for valuation improvements, attractive competitive dynamics, consolidation opportunities, competitive advantages, significant potential for recurring revenue, opportunities for operational improvement, attractive steady-state margins, high incremental margins, and attractive free cash flow characteristics .

The Company consummated its IPO on May 6, 2024, selling 28,750,000 Public Units, including 3,750,000 Option Units from the full exercise of the Over-Allotment Option, at a price of $10.00 per Public Unit, generating gross proceeds of $287,500,000 . Simultaneously, it sold 725,000 Private Placement Units to its Sponsor at $10.00 per unit, generating gross proceeds of $7,250,000 . A total of $287,500,000 from these proceeds was placed in a Trust Account . Each Public Unit consists of one Public Share and one-quarter of one Public Warrant, with each whole Public Warrant exercisable for one Class A Ordinary Share at $11.50 per share .

For the fiscal year ended December 31, 2025, the Company reported net income of $8,556,703 . This includes $12,494,752 of interest income earned on marketable securities and cash held in the Trust Account, offset by $3,938,049 of general and administrative costs . In comparison, for the year ended December 31, 2024, the Company had net income of $8,791,874, which included $9,622,647 of interest income from the Trust Account, offset by $830,773 of general and administrative costs . The basic and diluted net income per redeemable Class A ordinary share for 2025 was $0.23 , down from $0.34 in 2024 . The basic and diluted net income per non-redeemable Class A and B ordinary share was also $0.23 for 2025 , compared to $0.34 for 2024 .

As of December 31, 2025, the Company had marketable securities and cash held in the Trust Account totaling $307,617,399 , an increase from $296,122,647 as of December 31, 2024 . Cash held outside the Trust Account was $2,469 as of December 31, 2025 , a significant decrease from $2,412,564 as of December 31, 2024 . Total current assets were $161,703 as of December 31, 2025 , down from $2,849,738 in 2024 . Total liabilities were $10,235,469 as of December 31, 2025 , compared to $10,137,500 in 2024 . The Company had a working capital deficit of $11,266 as of December 31, 2025 . The redemption value for Class A ordinary shares subject to possible redemption was approximately $10.70 per share as of December 31, 2025 , up from $10.30 per share as of December 31, 2024 .

A significant operational development is the proposed PlusAI Business Combination. On June 5, 2025, the Company entered into the PlusAI Merger Agreement with Plus Automation, Inc. ("PlusAI") and its Merger Subs . This agreement was amended on September 8, 2025, to clarify the exchange of PlusAI Common Stock from PlusAI Options for SPAC Class B Common Stock , and again on September 18, 2025, to remove the closing condition requiring the Company to have $100 million in Available Closing SPAC Cash . The PlusAI Business Combination is expected to be consummated following shareholder approvals and satisfaction of other closing conditions . The aggregate consideration for PlusAI stockholders and vested equityholders will be based on a pre-money equity value of PlusAI of $1,200,000,000, subject to adjustments .

Business Outlook

The Company's primary objective is to complete its initial Business Combination, specifically the PlusAI Business Combination, by May 6, 2026, or by August 6, 2026, if a definitive agreement for an initial Business Combination, such as the PlusAI Merger Agreement, was executed by May 6, 2026 . The PlusAI Registration Statement was declared effective on January 12, 2026 , and the extraordinary general meeting of shareholders to approve the PlusAI Business Combination has been rescheduled to February 11, 2026 . The Board postponed the meeting to allow additional time for shareholder engagement, particularly following PlusAI's announcement of an expanded partnership with TRATON Group .

The Company intends to use substantially all of the funds held in the Trust Account, including interest earned (net of taxes and excluding the Deferred Fee), to complete its Business Combination . If share capital or debt is used as consideration, any remaining proceeds in the Trust Account will be used as working capital for the target business, other acquisitions, and growth strategies . The Company may need to obtain additional financing to complete its initial Business Combination, either due to transaction cash requirements or significant Public Share redemptions . In such cases, the Company may issue additional securities or incur debt .

Operationally, the Company expects to incur increased expenses as a public company, including legal, financial reporting, accounting, and auditing compliance costs, as well as due diligence expenses . The Company has Permitted Withdrawals from the Trust Account for working capital, limited to $1,000,000 annually from interest earned in excess of the initial deposit . For the year ended December 31, 2025, the Company withdrew $1,000,000 for working capital and has no further amounts available until May 6, 2026 . The Sponsor or its affiliates may provide Working Capital Loans up to $1,500,000 to fund deficiencies or transaction costs, which may be convertible into WCL Conversion Units at $10.00 per unit . As of January 13, 2026, the Company borrowed $250,000 against the WCL Promissory Note, leaving $1,250,000 available for withdrawal .

The Company's capital allocation plans include the potential payment of a Deferred Fee of $10,062,500 to the Underwriters upon completion of the initial Business Combination . Additionally, if the PlusAI Business Combination is consummated, Citigroup Global Markets Inc. will be entitled to a cash fee of $7,000,000 for capital market advisory services, with a potential additional fee of up to $3,000,000 at the discretion of the Company and PlusAI . The Advisor will also be reimbursed for reasonable incurred expenses not exceeding $500,000 without prior written consent . Legal fees of approximately $3,420,000 have been incurred in connection with the PlusAI Merger Agreement, which are contingent upon completion of the Business Combination and will include a premium ranging from 50% to 100% of incurred fees . Due diligence fees of $1,050,000 were incurred, with $900,000 paid and $150,000 remaining contingent on customer satisfaction and due upon consummation of a Business Combination .

The Company faces structural headwinds and execution risks, including the possibility of not completing the PlusAI Business Combination within the Combination Period, which would lead to liquidation and redemption of Public Shares . The Nasdaq Rules require SPACs to complete their initial Business Combination within 36 months of the IPO registration statement's effectiveness, and failure to meet this requirement could result in suspension of trading and delisting . The Company's liquidity condition and mandatory liquidation date raise substantial doubt about its ability to continue as a going concern . Furthermore, the Company's ability to complete an initial Business Combination could be adversely affected by changes in laws or regulations, downturns in financial markets, inflation, interest rate fluctuations, tariffs, supply chain disruptions, declines in consumer confidence, public health considerations, and geopolitical instability .

Risk Factors

The Company faces material risks including its status as a blank check company with no operating history or revenues, making its ability to achieve its business objective of completing an initial Business Combination uncertain. There is substantial doubt about the Company's ability to continue as a going concern due to its liquidity needs and the deadline for liquidating its Trust Account if a Business Combination is not completed by August 6, 2026 . The Company may not be able to complete the PlusAI Business Combination within the Combination Period, leading to liquidation and redemption of Public Shares, with Warrants expiring worthless. Intense competition from other entities, including other SPACs, private equity groups, and operating businesses, for attractive acquisition targets could increase costs or prevent the Company from finding a suitable target. Recent fluctuations in inflation and interest rates, military or other conflicts, and disruptions to capital markets could make it more difficult to consummate a Business Combination. Changes in laws or regulations, including the U.S. federal 1% excise tax on stock repurchases, or a failure to comply with them, may adversely affect the business. The availability of funds from interest income on the Trust Account for Permitted Withdrawals, limited to an annual $1,000,000 , may be insufficient to operate the business prior to a Business Combination. Cybersecurity incidents or attacks could result in information theft, data corruption, operational disruption, and financial loss. The Company's Public Shareholders may be held liable for claims by third parties against the Company to the extent of distributions received upon redemption of their Public Shares, and the per-share redemption amount could be less than the Redemption Price of approximately $10.70 if third-party claims reduce the Trust Account funds.

Management Priorities

Management's message emphasizes its commitment to completing the PlusAI Business Combination, which is the Company's current strategic priority. The Board of Directors decided to postpone the extraordinary general meeting to approve the PlusAI Business Combination from February 3, 2026, to February 11, 2026 , to allow additional time for shareholder engagement, particularly following PlusAI's announcement of an expanded partnership with TRATON Group . This indicates a focus on ensuring shareholder support and leveraging strategic partnerships for the target business. Management aims to identify and execute attractive Business Combination opportunities by leveraging the experience of its Management Team, M. Klein and Company, and Strategic and Operating Partners, with a focus on selecting high-quality targets at attractive valuations, negotiating favorable acquisition terms, and improving operational performance . The Company's strategic priorities include completing the PlusAI Business Combination before the end of the Combination Period, which is currently August 6, 2026 , and managing liquidity to sustain operations, including through potential Working Capital Loans of up to $1,500,000 from the Sponsor .

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — Overview
  2. [2] Item 1, Business — Overview
  3. [3] Item 1, Business — Overview
  4. [4] Item 1, Business — Status as a Public Company
  5. [5] Item 1, Business — Management Team
  6. [6] Item 1, Business — Management Team
  7. [7] Item 1, Business — Management Team
  8. [8] Item 1, Business — Initial Public Offering
  9. [9] Item 1, Business — Initial Public Offering
  10. [10] Item 1, Business — Initial Public Offering
  11. [11] Item 1, Business — Initial Public Offering
  12. [12] Item 7, MD&A — Results of Operations
  13. [13] Item 7, MD&A — Results of Operations
  14. [14] Item 7, MD&A — Results of Operations
  15. [15] Item 8, Note 2 — Net Income Per Ordinary Share
  16. [16] Item 8, Note 2 — Net Income Per Ordinary Share
  17. [17] Item 8, Note 2 — Net Income Per Ordinary Share
  18. [18] Item 8, Note 2 — Net Income Per Ordinary Share
  19. [19] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  20. [20] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  21. [21] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  22. [22] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  23. [23] Item 8, Consolidated Balance Sheets
  24. [24] Item 8, Consolidated Balance Sheets
  25. [25] Item 8, Consolidated Balance Sheets
  26. [26] Item 8, Consolidated Balance Sheets
  27. [27] Item 8, Note 1 — Liquidity, Capital Resources and Going Concern
  28. [28] Item 1, Business — Redemptions in Connection with Our Initial Business Combination
  29. [29] Item 8, Note 2 — Class A Ordinary Shares Subject to Possible Redemption
  30. [30] Item 1, Business — PlusAI Business Combination
  31. [31] Item 1, Business — PlusAI Business Combination
  32. [32] Item 1, Business — PlusAI Business Combination
  33. [33] Item 1, Business — PlusAI Business Combination
  34. [34] Item 1, Business — Consideration
  35. [35] Item 7, MD&A — Overview
  36. [36] Item 7, MD&A — Recent Developments
  37. [37] Item 7, MD&A — Recent Developments
  38. [38] Item 7, MD&A — Recent Developments
  39. [39] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  40. [40] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  41. [41] Item 1, Business — Effecting our Initial Business Combination
  42. [42] Item 1, Business — Effecting our Initial Business Combination
  43. [43] Item 7, MD&A — Results of Operations
  44. [44] Item 7, MD&A — Permitted Withdrawals
  45. [45] Item 7, MD&A — Permitted Withdrawals
  46. [46] Item 7, MD&A — Working Capital Loans
  47. [47] Item 7, MD&A — Recent Developments
  48. [48] Item 7, MD&A — Underwriting Agreement
  49. [49] Item 7, MD&A — Advisory Agreement
  50. [50] Item 7, MD&A — Advisory Agreement
  51. [51] Item 7, MD&A — Legal and Due Diligence Fees
  52. [52] Item 7, MD&A — Legal and Due Diligence Fees
  53. [53] Item 1A, Risk Factors — Risks Relating to our Search for, and Consummation of or Inability to Consummate, a Business Combination
  54. [54] Item 1, Business — Initial Public Offering
  55. [55] Item 7, MD&A — Liquidity, Capital Resources and Going Concern
  56. [56] Item 8, Note 1 — Risks and Uncertainties
  57. [57] Item 1A, Risk Factors — There is substantial doubt about our ability to continue as a “going concern.”
  58. [58] Item 1A, Risk Factors — the availability to us of funds from interest income on the Trust Account balance for Permitted Withdrawals may be insufficient to operate our business prior to the Business Combination
  59. [59] Item 1, Business — Redemption Rights for Public Shareholders upon Completion of our Initial Business Combination
  60. [60] Item 7, MD&A — Recent Developments
  61. [61] Item 7, MD&A — Recent Developments
  62. [62] Item 1, Business — Management Team
  63. [63] Item 8, Note 1 — Liquidity, Capital Resources and Going Concern
  64. [64] Item 8, Note 1 — Liquidity, Capital Resources and Going Concern

Analysis on 5/20/2026